Institute of Biomedicine - News

Kuopio Brain & Mind, a new regional network of Neurocenter Finland, promotes research and collaboration in the field of brain health in eastern Finland.

Academy Research Fellow Vittorio Fortino has been awarded a grant by Jane and Aatos Erkko Foundation for the research project Combining multi-omics data and AI for disease subtype and drug discoveries.

The Frontiers in Health Sciences seminar series will continue in October–December 2021 with online lectures by leading Finnish scientists. The lectures are open to all.

Researchers discovered how comparing genomic changes in cancer cells eradicated by and resistant to treatment can be used to identify molecular targets for prostate cancer therapy.

A new study provides a novel genetic tool to identify C9orf72 repeat expansion-carrying frontotemporal lobar degeneration or ALS patients from large population-based cohorts.

The doctoral thesis of A. B. M. Kaiser Manjur, M.Sc., provides novel insights into two medically important transcription factors, glucocorticoid receptor (GR) and androgen receptor (AR).

A new study suggests that skin fibroblasts from frontotemporal dementia patients may be useful in investigating underlying disease mechanisms as well as in biomarker and drug research.

Researchers at the University of Eastern Finland have uncovered potential mechanisms by which microRNAs (miRNA) drive atherogenesis in a cell-type-specific manner.

Researchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a therapeutic target in early Alzheimer’s disease.